Richard Pulik Roivant Sciences Ltd. (ROIV) insider trading activity

Richard Pulik is CFO of Roivant Sciences Ltd.. Currently has a direct ownership of 290,434 shares of ROIV, which is worth approximately $3.1 Million. The most recent transaction as insider was on Jun 28, 2024, when has been sold 2,340 shares (Common Shares) at a price of $10.57 per share, resulting in proceeds of $24,733. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 290K

1.56% 3M change

2.49% 12M change

Total Value Held $3.1 Million

Richard Pulik Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 28 2024	SELL Payment of exercise price or tax liability	$24,733 $10.57 p/Share	2,340 Reduced 0.8%	290,434 Common Shares
Jun 20 2024	SELL Payment of exercise price or tax liability	$22,993 $10.8 p/Share	2,129 Reduced 0.73%	290,572 Common Shares
May 28 2024	SELL Payment of exercise price or tax liability	$25,353 $10.83 p/Share	2,341 Reduced 0.79%	292,701 Common Shares
Apr 28 2024	SELL Payment of exercise price or tax liability	$25,810 $11.03 p/Share	2,340 Reduced 0.79%	295,042 Common Shares
Apr 22 2024	BUY Grant, award, or other acquisition	-	38,685 Added 11.51%	297,382 Common Shares
Apr 20 2024	SELL Payment of exercise price or tax liability	$89,066 $10.46 p/Share	8,515 Reduced 3.19%	258,697 Common Shares
Mar 28 2024	SELL Payment of exercise price or tax liability	$24,674 $10.54 p/Share	2,341 Reduced 0.87%	267,212 Common Shares

Feb 28 2024	SELL Payment of exercise price or tax liability	$19,087 $11.71 p/Share	1,630 Reduced 0.6%	269,553 Common Shares
Jan 28 2024	SELL Payment of exercise price or tax liability	$19,661 $10.37 p/Share	1,896 Reduced 0.69%	271,183 Common Shares
Dec 28 2023	SELL Payment of exercise price or tax liability	$21,750 $11.37 p/Share	1,913 Reduced 0.7%	273,079 Common Shares
Nov 29 2023	SELL Other acquisition or disposition	$21,546 $9.13 p/Share	2,360 Reduced 0.85%	274,922 Common Shares
Oct 30 2023	SELL Other acquisition or disposition	$19,800 $8.39 p/Share	2,360 Reduced 0.84%	277,352 Common Shares
Sep 29 2023	SELL Other acquisition or disposition	$29,448 $11.86 p/Share	2,483 Reduced 0.88%	279,712 Common Shares
Aug 29 2023	SELL Other acquisition or disposition	$26,497 $11.19 p/Share	2,368 Reduced 0.83%	282,195 Common Shares
Aug 01 2023	SELL Other acquisition or disposition	$27,349 $11.86 p/Share	2,306 Reduced 0.8%	284,563 Common Shares
Jun 29 2023	SELL Other acquisition or disposition	$16,853 $10.11 p/Share	1,667 Reduced 0.58%	283,373 Common Shares
May 31 2023	SELL Other acquisition or disposition	$15,535 $9.08 p/Share	1,711 Reduced 0.6%	285,040 Common Shares
May 01 2023	SELL Other acquisition or disposition	$14,352 $8.61 p/Share	1,667 Reduced 0.58%	286,751 Common Shares
Apr 20 2023	BUY Grant, award, or other acquisition	-	66,710 Added 18.78%	288,418 Common Shares
Mar 29 2023	SELL Other acquisition or disposition	$12,046 $7.35 p/Share	1,639 Reduced 0.73%	221,708 Common Shares
Mar 01 2023	SELL Open market or private sale	$15,448 $8.08 p/Share	1,912 Reduced 0.85%	223,347 Common Shares

Richard Pulik

CFO

London, X0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ROIV shares.

Notify only if

Value

Insider Trading

Get notified when an Roivant Sciences Ltd. insider buys or sells ROIV shares.

Notify only if

Operation

Value

Type

News

Receive news related to Roivant Sciences Ltd.

Track Activities on ROIV

Account